Repeated inhalation exposure to octamethylcyclotetrasiloxane produces hepatomegaly, transient hepatic hyperplasia, and sustained hypertrophy in female Fischer 344 rats in a manner similar to phenobarbital. 2001

J M McKim, and G B Kolesar, and P A Jean, and L S Meeker, and P C Wilga, and R Schoonhoven, and J A Swenberg, and J I Goodman, and R H Gallavan, and R G Meeks
Dow Corning Corporation, 2200 W. Salzburg Road, Midland, Michigan 48686-0994, USA.

Octamethylcyclotetrasiloxane (D4) has been described as a phenobarbital-like inducer of hepatic enzymes. Phenobarbital (PB) and phenobarbital-like chemicals induce transient hepatic and thyroid hyperplasia and sustained hypertrophy in rats and mice. The extent to which these processes are involved with D4-induced hepatomegaly is not known. The present study has evaluated the effects of repeated inhalation exposure to D4 vapors on hepatic and thyroid cell proliferation and hypertrophy with respect to time and exposure concentration. Female Fischer 344 rats were exposed via whole body inhalation to 0 ppm D4, 700 ppm D4 vapors (6 h/day; 5 days/week), or 0.05% PB in drinking water over a 4-week period. Incorporation of 5'-bromo-2-deoxyuridine (BrdU) and the abundance of proliferating cell nuclear antigen were used as indicators of cell proliferation. Designated animals from each treatment group were euthanized on study days 6, 13, and 27. The effect of D4 exposure concentration on hepatic cell proliferation was evaluated at 0, 7, 30, 70, 150, 300, or 700 ppm. Liver-to-body weight ratios in animals exposed to 700 ppm D4 were increased 18, 20, and 22% over controls while PB-treated animals showed increases of 33, 27, and 27% over controls on days 6, 13, and 27 respectively. Hepatic incorporation of BrdU following exposure to D4 was highest on day 6 (labeling index = 15-22%) and was at or below control values by day 27. This pattern of transient hyperplasia was observed in all hepatic lobes examined and was similar to the pattern observed following treatment with PB.

UI MeSH Term Description Entries
D006965 Hyperplasia An increase in the number of cells in a tissue or organ without tumor formation. It differs from HYPERTROPHY, which is an increase in bulk without an increase in the number of cells. Hyperplasias
D006984 Hypertrophy General increase in bulk of a part or organ due to CELL ENLARGEMENT and accumulation of FLUIDS AND SECRETIONS, not due to tumor formation, nor to an increase in the number of cells (HYPERPLASIA). Hypertrophies
D008099 Liver A large lobed glandular organ in the abdomen of vertebrates that is responsible for detoxification, metabolism, synthesis and storage of various substances. Livers
D010634 Phenobarbital A barbituric acid derivative that acts as a nonselective central nervous system depressant. It potentiates GAMMA-AMINOBUTYRIC ACID action on GABA-A RECEPTORS, and modulates chloride currents through receptor channels. It also inhibits glutamate induced depolarizations. Phenemal,Phenobarbitone,Phenylbarbital,Gardenal,Hysteps,Luminal,Phenobarbital Sodium,Phenobarbital, Monosodium Salt,Phenylethylbarbituric Acid,Acid, Phenylethylbarbituric,Monosodium Salt Phenobarbital,Sodium, Phenobarbital
D011916 Rats, Inbred F344 An inbred strain of rat that is used for general BIOMEDICAL RESEARCH purposes. Fischer Rats,Rats, Inbred CDF,Rats, Inbred Fischer 344,Rats, F344,Rats, Inbred Fisher 344,CDF Rat, Inbred,CDF Rats, Inbred,F344 Rat,F344 Rat, Inbred,F344 Rats,F344 Rats, Inbred,Inbred CDF Rat,Inbred CDF Rats,Inbred F344 Rat,Inbred F344 Rats,Rat, F344,Rat, Inbred CDF,Rat, Inbred F344,Rats, Fischer
D001973 Bromodeoxyuridine A nucleoside that substitutes for thymidine in DNA and thus acts as an antimetabolite. It causes breaks in chromosomes and has been proposed as an antiviral and antineoplastic agent. It has been given orphan drug status for use in the treatment of primary brain tumors. BUdR,BrdU,Bromouracil Deoxyriboside,Broxuridine,5-Bromo-2'-deoxyuridine,5-Bromodeoxyuridine,NSC-38297,5 Bromo 2' deoxyuridine,5 Bromodeoxyuridine,Deoxyriboside, Bromouracil
D004247 DNA A deoxyribonucleotide polymer that is the primary genetic material of all cells. Eukaryotic and prokaryotic organisms normally contain DNA in a double-stranded state, yet several important biological processes transiently involve single-stranded regions. DNA, which consists of a polysugar-phosphate backbone possessing projections of purines (adenine and guanine) and pyrimidines (thymine and cytosine), forms a double helix that is held together by hydrogen bonds between these purines and pyrimidines (adenine to thymine and guanine to cytosine). DNA, Double-Stranded,Deoxyribonucleic Acid,ds-DNA,DNA, Double Stranded,Double-Stranded DNA,ds DNA
D005260 Female Females
D006529 Hepatomegaly Enlargement of the liver. Enlarged Liver,Liver, Enlarged
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia

Related Publications

J M McKim, and G B Kolesar, and P A Jean, and L S Meeker, and P C Wilga, and R Schoonhoven, and J A Swenberg, and J I Goodman, and R H Gallavan, and R G Meeks
July 1999, Toxicological sciences : an official journal of the Society of Toxicology,
J M McKim, and G B Kolesar, and P A Jean, and L S Meeker, and P C Wilga, and R Schoonhoven, and J A Swenberg, and J I Goodman, and R H Gallavan, and R G Meeks
January 2002, International journal of toxicology,
J M McKim, and G B Kolesar, and P A Jean, and L S Meeker, and P C Wilga, and R Schoonhoven, and J A Swenberg, and J I Goodman, and R H Gallavan, and R G Meeks
January 2023, Toxicology letters,
J M McKim, and G B Kolesar, and P A Jean, and L S Meeker, and P C Wilga, and R Schoonhoven, and J A Swenberg, and J I Goodman, and R H Gallavan, and R G Meeks
October 2017, Toxicology letters,
J M McKim, and G B Kolesar, and P A Jean, and L S Meeker, and P C Wilga, and R Schoonhoven, and J A Swenberg, and J I Goodman, and R H Gallavan, and R G Meeks
February 2000, Drug metabolism and disposition: the biological fate of chemicals,
J M McKim, and G B Kolesar, and P A Jean, and L S Meeker, and P C Wilga, and R Schoonhoven, and J A Swenberg, and J I Goodman, and R H Gallavan, and R G Meeks
November 1999, Drug and chemical toxicology,
J M McKim, and G B Kolesar, and P A Jean, and L S Meeker, and P C Wilga, and R Schoonhoven, and J A Swenberg, and J I Goodman, and R H Gallavan, and R G Meeks
March 2008, Inhalation toxicology,
J M McKim, and G B Kolesar, and P A Jean, and L S Meeker, and P C Wilga, and R Schoonhoven, and J A Swenberg, and J I Goodman, and R H Gallavan, and R G Meeks
December 2016, Environmental toxicology,
J M McKim, and G B Kolesar, and P A Jean, and L S Meeker, and P C Wilga, and R Schoonhoven, and J A Swenberg, and J I Goodman, and R H Gallavan, and R G Meeks
November 2015, Chemico-biological interactions,
J M McKim, and G B Kolesar, and P A Jean, and L S Meeker, and P C Wilga, and R Schoonhoven, and J A Swenberg, and J I Goodman, and R H Gallavan, and R G Meeks
July 1991, Toxicology and industrial health,
Copied contents to your clipboard!